Strategies to improve antimicrobial utilization with a special focus on developing countries
Antimicrobial resistance (AMR) is a high priority across countries as it increases morbidity,
mortality and costs. Concerns with AMR have resulted in multiple initiatives internationally …
mortality and costs. Concerns with AMR have resulted in multiple initiatives internationally …
Response to the novel corona virus (COVID-19) pandemic across Africa: successes, challenges, and implications for the future
OO Ogunleye, D Basu, D Mueller, J Sneddon… - Frontiers in …, 2020 - frontiersin.org
Background The COVID-19 pandemic has already claimed considerable lives. There are
major concerns in Africa due to existing high prevalence rates for both infectious and non …
major concerns in Africa due to existing high prevalence rates for both infectious and non …
Tackling antimicrobial resistance across sub-Saharan Africa: Current challenges and implications for the future
B Godman, A Egwuenu, E Wesangula… - Expert Opinion on …, 2022 - Taylor & Francis
Introduction Antimicrobial resistance (AMR) is a concern as this increases morbidity,
mortality, and costs, with sub-Saharan Africa having the highest rates globally. Concerns …
mortality, and costs, with sub-Saharan Africa having the highest rates globally. Concerns …
Current rates of purchasing of antibiotics without a prescription across sub-Saharan Africa; rationale and potential programmes to reduce inappropriate dispensing …
TM Sono, E Yeika, A Cook, A Kalungia… - Expert review of anti …, 2023 - Taylor & Francis
Introduction Antimicrobial resistance (AMR) is a global concern. Currently, the greatest
mortality due to AMR is in Africa. A key driver continues to be high levels of dispensing of …
mortality due to AMR is in Africa. A key driver continues to be high levels of dispensing of …
Ongoing efforts to improve antimicrobial utilization in hospitals among African countries and implications for the future
There are serious concerns with rising antimicrobial resistance (AMR) across countries
increasing morbidity, mortality and costs. These concerns have resulted in a plethora of …
increasing morbidity, mortality and costs. These concerns have resulted in a plethora of …
Rapid assessment of price instability and paucity of medicines and protection for COVID-19 across Asia: findings and public health implications for the future
Background: Countries have introduced a variety of measures to prevent and treat COVID-
19 with medicines and personal protective equipment (PPE), with some countries adopting …
19 with medicines and personal protective equipment (PPE), with some countries adopting …
Coronavirus disease 2019 (COVID-19) pandemic across Africa: current status of vaccinations and implications for the future
The introduction of effective vaccines in December 2020 marked a significant step forward in
the global response to COVID-19. Given concerns with access, acceptability, and hesitancy …
the global response to COVID-19. Given concerns with access, acceptability, and hesitancy …
Progress on the national action plan of Pakistan on antimicrobial resistance (AMR): A narrative review and the implications
Introduction The emergence of antimicrobial resistance (AMR) is a threat to public health. In
2015, the World Health Organization (WHO) introduced a global action plan to tackle AMR in …
2015, the World Health Organization (WHO) introduced a global action plan to tackle AMR in …
Challenges and innovations brought about by the COVID-19 pandemic regarding medical and pharmacy education especially in Africa and implications for the future
Background: Multiple measures introduced early to restrict COVID-19 have dramatically
impacted the teaching of medical and pharmacy students, exacerbated by the lack of …
impacted the teaching of medical and pharmacy students, exacerbated by the lack of …
Evidence-based public policy making for medicines across countries: findings and implications for the future
Aim: Global expenditure on medicines is rising up to 6% per year driven by increasing
prevalence of non-communicable diseases (NCDs) and new premium priced medicines for …
prevalence of non-communicable diseases (NCDs) and new premium priced medicines for …